# Henry Schein (HSIC) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/HSIC
## Company Profile
- Ticker: HSIC
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 84.84 USD
- Market cap: 8662230202.28 USD
- Last updated: 2026-10-06
## Business Overview
### Healthcare Products and Services Platform
Henry Schein supplies products, services, and technology to office-based dental and medical practitioners, dental laboratories, institutional clinics, and other alternate-care sites. Its scale combines a broad product catalog with advisory, operational, and clinical support.
### Dental Distribution and Equipment
The company distributes dental consumables, instruments, equipment, and digital workflow systems. It also supports equipment installation, repair, practice transitions, and other services that deepen its relationships with dental offices and laboratories.
### Medical Distribution
Henry Schein serves physician practices, ambulatory surgery centers, urgent-care facilities, and other non-hospital settings with pharmaceuticals, vaccines, diagnostics, equipment, and routine medical supplies.
### Specialty Products
The specialty portfolio includes dental implants, endodontic products, orthodontic solutions, and other clinically differentiated offerings. These products complement the core distribution business and give the company greater exposure to procedure-driven categories.
### Technology and Value-Added Services
Henry Schein provides practice-management software, revenue-cycle services, financial solutions, consulting, and other tools intended to improve clinical and administrative workflows. A centralized, automated distribution network supports more than 300,000 branded and private-label products.
## Why The Stock Is Moving

As of Oct 6, 2026, HSIC closed up 0.72% at $84.84. No new same-company headline was identified in the current news window.

## Recent News
- 2017-05-23 12:00 EST — [Henry Schein to Present at Four Conferences in June](https://biopharmsignal.com/news/HSIC/henry-schein-to-present-at-four-conferences-in-june-89da7aa8) — Source: Henry Schein